Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells

Biochemical Pharmacology

Volumn 59, Issue 10, 2000, Pages 1265-1275

  Desai, Sejal H ^a   Boskovic, Goran ^a   Eastham, Linda ^a   Dawson, Marcia ^b   Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Palo Alto Institute of Molecular Medicine   (United States)

Author keywords

Differentiation; Melanoma; Proliferation; Receptor selective retinoids

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CYCLOPROPYL]BENZOIC ACID; ALITRETINOIN; CELL NUCLEUS RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; SR 11254; SR 12246; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; GENETIC TRANSCRIPTION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOENZYMES; LIGANDS; MELANOMA, EXPERIMENTAL; MICE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; RECEPTORS, RETINOIC ACID; RETINOIDS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034657010     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00269-0     Document Type: Article

References (60)

1. Strickland S., Smith K.K., Marotti K.R. Hormonal induction of differentiation in teratocarcinoma stem cells Generation of parietal endoderm by retinoic acid and dibutyryl cAMP . Cell. 21:1980;347-355.
2. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 77:1980;2936-2940.
3. Breitman T.R., Collins S.J., Keene B.R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood. 57:1981;1000-1004.
4. Garg L.C., Brown J.C. Friend erythroleukemia cell differentiation Induction by retinoids . Differentiation. 25:1983;79-83.
5. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst. 68:1981;589-596.
6. Allenby G., Bocquel M.-T., Saunders M., Kazmer S., Speck J., Rosenberger M., Lovey A., Kastner F., Grippo J.F., Chambon P., Levin A.A. Retinoic acid receptors and retinoid X receptors Interactions with endogenous retinoic acids . Proc Natl Acad Sci USA. 90:1993;30-34.
7. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J.F. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα Nature. 355:1992;359-361.
8. Giguere V., Ong S., Segui P., Evans R. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
9. Petkovich M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;444-450.
10. Zelent A., Krust A., Petkovich M., Kastner P., Chambon P. Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin. Nature. 339:1989;714-717.
11. Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 345:1990;224-229.
12. Hoopes C.W., Taketo M., Ozato K., Liu Q., Howard T.A., Linney E., Seldin M.F. Mapping of the mouse Rxr loci encoding nuclear retinoid X receptors RXRα, RXRβ, and RXRγ Genomics. 14:1992;611-617.
13. de The H., Marchio A., Tiollais P., Dejean A. Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J. 8:1989;429-433.
14. 3 receptors. Cell. 65:1991;1255-1266.
15. Mader S., Leroy P., Chen J.-Y., Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors . J Biol Chem. 268:1993;591-600.
16. Leid M., Kastner P., Lyons R., Nakshari H., Saunders M., Zacharewski T., Chen J.-Y., Staub A., Garnier J.-M., Mader S., Chambon P. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 68:1992;377-395.
17. Yu V.C., Deisert C., Andersen B., Holloway J.M., Devary O.V., Näär A.M., Kim S.Y., Boutin J.-M., Glass C.K., Rosenfeld M.G. RXRβ, A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 67:1991;1251-1266.
18. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., Hunziker W. Two nuclear signalling pathways for vitamin D. Nature. 361:1993;657-660.
19. Widom R.L., Rhee M., Karathanasis S.K. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXRα and retinoic acid. Mol Cell Biol. 12:1992;3380-3389.
20. Kliewer S.A., Umesono K., Heyman R.H., Mangelsdorf D.J., Dyck J.A., Evans R.M. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA. 89:1992;1448-1452.
21. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
22. Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
23. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
24. Niles R.M., Loewy B.P. Induction of protein kinase C in mouse melanoma cells by retinoic acid. Cancer Res. 49:1989;4483-4487.
25. Niles R.M. Retinoic acid-induced arrest of mouse melanoma cells in G1 without inhibition of protein synthesis. In Vitro. 23:1987;803-804.
26. α plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem. 267:1992;13356-13360.
27. Desai S., Niles R.M. Characterization of retinoic acid-induced AP-1 activity in B16 mouse melanoma cells. J Biol Chem. 272:1997;12809-12815.
28. Xiao Y., Desai D., Quick T.C., Niles R.M. Control of retinoic acid receptor expression in mouse melanoma cells by cyclic AMP. J Cell Physiol. 167:1996;413-421.
29. Desai D., Niles R.M. Expression and regulation of retinoid X receptors in B16 melanoma cells. J Cell Physiol. 165:1995;349-357.
30. Lehmann J.M., Dawson M.I., Hobbs P.D., Husmann M., Pfahl M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res. 51:1991;4804-4809.
31. Hashimoto Y., Kagechika H., Shudo K. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RARs). Biochem Biophys Res Commun. 166:1990;1300-1307.
32. Dawson M.I., Chao W.R., Pine P., Jong L., Hobbs P.D., Rudd C.K., Quick T.C., Niles R.M., Zhang X.K., Lombardo A., Ely K.R., Shroot B., Fontana J.A. Correlation of retinoid binding affinity to retinoic acid receptor α with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res. 55:1995;4446-4451.
33. Meyskens F.L. Jr, Salmon S.E. Inhibition of human melanoma colony formation by retinoids. Cancer Res. 39:1979;4055-4057.
34. Lotan R., Lotan D., Kadouri A. Comparison of retinoic acid effects on anchorage-dependent growth, anchorage-independent growth and fibrinolytic activity of neoplastic cells. Exp Cell Res. 141:1982;79-86.
35. Rosenbaum S., Niles R.M. Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells. Arch Biochem Biophys. 294:1992;123-129.
36. Schule R., Rangarajan P., Yang N., Kleiwer S., Ransone L.J., Bolado J., Verma I.M., Evans R.M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA. 88:1991;6092-6096.
37. Yang-Yen J.-F., Hang X.-K., Graupner G., Tzukerman M., Sakamoto B., Karin M., Pfahl M. Antagonism between retinoic acid receptors and AP-1 Implications for tumor promotion and inflammation . New Biol. 3:1991;1206-1210.
38. Nagpal S., Athanikar J., Chandraratna R.A.S. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α J Biol Chem. 270:1995;923-927.
39. Kurokawa R., DiRenzo J., Boehm M., Sugarman J., Gloss B., Rosenfeld M.G., Heyman R.A., Glass C.K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371:1994;528-531.
40. Apfel C.M., Kamber M., Klaus M., Mohr P., Keidel S., LeMotte P.K. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem. 270:1995;30765-30772.
41. Roy B., Taneja R., Chambon P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol. 15:1995;6481-6487.
42. Horn V., Minucci S., Ogryzko V.V., Adamson E.D., Howard B.H., Levin A.A., Ozato K. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J. 10:1996;1071-1077.
43. Lohnes D., Mark M., Mendelsohn C., Dollé P., Dierich A., Gorry P., Gansmuller A., Chambon P. Function of the retinoic acid receptors (RARs) during development. (I) Craniofacial and skeletal abnormalities in RAR double mutants. Development. 120:1994;2723-2748.
44. Lufkin T., Lohnes D., Mark M., Dierich A., Gorry P., Gaub M.-P., LeMeur M., Chambon P. High postnatal lethality and testis degeneration in retinoic acid receptor α mutant mice. Proc Natl Acad Sci USA. 90:1993;7225-7229.
45. Luo J., Sucov H.M., Bader J.-A., Evans R.M., Giguère V. Compound mutants for retinoic acid receptor (RAR) β and RARα1 reveal developmental functions for multiple RARβ isoforms. Mech Dev. 55:1996;33-44.
46. Taneja R., Roy B., Plassat J.-L., Zusi C.F., Ostrowski J., Reczek P.R., Chambon P. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc Natl Acad Sci USA. 93:1996;6197-6202.
47. Ghyselinck N.B., Dupe V., Dierich A., Messaddeo N., Garnier J.-M., Rochette-Egly C., Chambon P., Mark M. Role of the retinoic acid receptor β (RARβ) during mouse development. Int J Dev Biol. 41:1997;425-447.
48. Boylan J.F., Lufkin T., Achkar C.C., Taneja R., Chambon P., Gudas L.J. Targeted disruption of retinoic acid receptor α (RAR α) and RAR γ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol. 15:1995;843-851.
49. Dawson M.I., Jong L., Hobbs P.D., Cameron J.F., Chao W.-R., Pfahl M., Lee M.-O., Shroot B., Pfahl M. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem. 38:1995;3368-3383.
50. Dawson M.I., Elstner E., Kizaki M., Chen D.L., Pakkala S., Kerner B., Koeffler H.P. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood. 84:1994;446-452.
51. Shiohara M., Dawson M.I., Hobbs P.D., Sawai N., Higuchi T., Koike K., Komiyama A., Koeffler H.P. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood. 93:1999;2057-2066.
52. Naby L., Thomazy V.A., Shipley G.L., Fesus L., Lamph V., Heyman R.B., Chandraratna R.A., Davies P.J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol. 15:1995;3548-3551.
53. de Vos S., Dawson M.I., Holden S., Le T., Wang A., Cho S.K., Chen D.-L., Koeffler H.P. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells. Prostate. 32:1997;115-121.
54. Wu Q., Dawson M.I., Zheng Y., Hobbs P.D., Agadir A., Jong L., Li Y., Liu R., Lin B., Zhang X.-K. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol. 17:1997;6598-6608.
55. Vivat V., Zechel C., Wurtz J.M., Bourguet W., Kagechika H., Umemiya H., Shudo K., Moras D., Gronemeyer H., Chambon P. A mutation mimicking ligand-induced confirmational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 16:1997;5697-5709.
56. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9:1995;769-782.
57. Mukherjee R., Davies P.J., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., Hamann L.G., Boehm M.F., Mondon C.E., Nadzan A.M., Paterniti J.R. Jr, Heyman R.A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386:1997;407-410.
58. Lopez-Boado Y., Klaus M., Dawson M.I., Lopez-Otin C. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARα-dependent signaling pathway. J Biol Chem. 271:1996;32105-32111.
59. Jiang H., Waxman S., Fisher P.B. Regulation of c-fos, c-jun and jun-B gene expression in human melanoma cells induced to terminally differentiate. Mol Cell Differ. 1:1993;197-214.
60. Mascrez B., Mark M., Dierich A., Ghyselinck N.B., Kastner P., Chambon P. The RXRα ligand-dependent activation function 2 (AF-2) is important for mouse development. Development. 125:1998;4691-4707.